Molnupiravir
ATC J05AB18 · 4 markets · 6 records
AU 3 records · 2 strengths
- 200 mgcapsuleLagevrio 200mg capsulesLAGEVRIO molnupiravir 200 mg capsules bottle
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 1 records · 1 strengths
- 200 mgcapsuleLagevrio 200mg capsules
CN 1 records · 1 strengths
- 200 mgcapsule利卓瑞莫诺拉韦
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | GB | AU | CN | EU |
|---|---|---|---|---|
| 200 mgRecorded as: 0.2 g capsule | Lagevrio 200mg capsules | Lagevrio 200mg capsules LAGEVRIO molnupiravir 200 mg capsules bottle | 利卓瑞莫诺拉韦 | |
unknown | Lagevrio 200mg capsules | Lagevrio 200mg capsules |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.